Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05396885
Title Study of CART-ddBMCA in Relapsed or Refractory Multiple Myeloma (iMMagine-1)
Acronym iMMagine-1
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Arcellx, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.